1.8373
13-February-25 11:32:50
15 minutes delayed
Stocks
-0.0527
-2.79%
Today's range
1.8113 - 1.9600
ISIN
N/A
Source
NASDAQ
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
30 Jan 2025 07:00:00 By Nasdaq GlobeNewswire